explore -WSS

explore

author：knowledge 2025-09-29 21:26:04 - browse：544

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Sickle cell gene therapy cures need to be accessible in Africa

WSS

States should stop sabotaging methadone treatment reform

Why the world’s most expensive drug might be worth the price

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Oprah kicked off a national conversation on obesity. Let's have it

Merck drug for rare lung condition set for approval in U.S.

Vermont grapples with historic flooding as more rainstorms head for Northeast

focus

explore

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

France's anti

Medical leaders decry Supreme Court decision on affirmative action

Abortion pill Supreme Court ruling could impact entire drug industry

What does generative AI mean for health care? We asked experts

Decaf coffee targeted by food safety group under obscure FDA rule

Apple is now the first public company to be valued at $3 trillion

Abortion pill Supreme Court ruling could impact entire drug industry

Virginia high school admissions case could be legal follow

A Greenpeace activist is fined for crash

knowledge

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

A Greenpeace activist is fined for crash

After half a century, Israel moves to evict squatter from his cave home on the beach

Will generative AI in health care meet the fate of IBM's Dr. Watson?

States should stop sabotaging methadone treatment reform

leisure time

Wikipedia

hotspot

explore